Bayer has launched Baycox Iron (36mg/ml toltrazuril plus 182 mg/ml gleptoferron) suspension for injection for piglets across Europe following marketing authorisation from the European Commission.
Baycox Iron Injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.
Professor Nicole Kemper, director of the Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour at the University of Veterinary Medicine Hannover, Germany, said: “Piglets go through intense handling in their first days of life. While this is done to give them a better start to life and protect them from disease, it can also cause a lot of stress.
“Measures to reduce the need for piglet handling can make an important contribution to enhancing piglet well-being in the farrowing pen.”
Professor Kemper said that coccidiosis and iron deficiency in piglets are among every swine professionals’ key concerns.
Octavio Orlovsky Eckhardt, Bayer’s head of species marketing swine, added: “A combination therapy that can effectively address these concerns with reduced handling can make a real difference for pig health and well-being.
“At the same time, farmers and workers can benefit from the reduced labour. For example, on a 1,000 sow farm, the reduced complexity is estimated to save up to one full work day every month.”
